Cancer trials support unit IDIQ: task order 6A: electronic patient-reported outcomes (pros)
Ended Awarded Last action
- Contract number
- 75N91022F00003
- Awardee
-
Westat, Inc. UEI NVUWAFWQ57S5
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $2,316,674
Award facts
- Opportunity
-
- Cancer Trials Support Unit Pre-Solicitation · 75N91021R00021 · Posted Sep 10, 2021
- Contract value 58% obligated
-
- $2,316,673.88 Current, with exercised options
- $3,987,201.88 Potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 3 offers Multiple Award, Fair Opportunity
- Pricing
- Cost Plus Fixed Fee
- Place of performance
- Rockville, MD 20850, USA
- Legislative mandates
-
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Change Order | $677,170 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $818,041 | |
| Other Administrative Action | $0 | |
| Original award | $821,463 |
About this award
This is a task order awarded under the Cancer Trials Support Unit Indefinite Delivery Indefinite Quantity (IDIQ) contract, issued by the National Cancer Institute (NCI), a civilian agency. The task order, valued at $3,987,201.88, is for electronic patient-reported outcomes (ePROs) support for cancer clinical trials. The prime contractor is Westat, Inc., a professional services firm with extensive experience supporting federal health and research programs. This task order does not have a set-aside designation. The larger IDIQ contract provides broad-based support for cancer clinical trials, allowing the NCI to issue task orders for specialized services as needed.
Quick answers
Who was awarded contract 75N91022F00003?
75N91022F00003 was awarded to Westat, Inc. by National Cancer Institute (National Institutes of Health) on August 1, 2022.
How much is contract 75N91022F00003 worth?
The government has obligated $2,316,674 on 75N91022F00003. Its potential value, with all options, is $3,987,202.
Is contract 75N91022F00003 an order under another contract?
Yes. 75N91022F00003 is a delivery order under 75N91022D00009, an indefinite delivery contract, on Cancer Trials Support Unit.
Was contract 75N91022F00003 competed?
The extent of competition for 75N91022F00003 was full and open competition. The government received 3 offers.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award